GO:0035050 embryonic heart tube development: Morphogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035050 embryonic heart tube development describes the progression of the embryonic heart tube from its formation to its mature structure, beginning with the heart rudiment derived from the heart field.
• The process is initiated by cardiac progenitor specification and migration, followed by folding of the cardiac crescent into a linear tube, then looping and chamber formation.
• Key genes include NKX2-5, TBX5, GATA4, MEF2C, HAND1, HAND2, and ISL1, which regulate cardiac progenitor identity, tube morphogenesis, and chamber specification.
• Disruption of embryonic heart tube development causes congenital heart defects (CHDs) such as septal defects, conotruncal anomalies, and left ventricular hypoplasia.
• Model systems for studying this process include human pluripotent stem cell-derived embryo models, Drosophila heart development, and engineered heart tube platforms.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in embryonic heart tube development.
Description
Embryonic heart tube development (GO:0035050) is the biological process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure. The heart tube forms as the heart rudiment from the heart field, a specialized population of cardiac progenitors specified during gastrulation. This process is one of the earliest and most critical events in organogenesis, establishing the structural foundation for all subsequent cardiac chamber formation, septation, and valve development. Researchers study GO:0035050 because defects in heart tube morphogenesis are a major cause of congenital heart defects (CHDs), the most common human birth defects. Understanding the molecular and cellular mechanisms that govern heart tube development is therefore essential for developmental biology, regenerative medicine, and translational cardiology.
embryonic heart tube development At A Glance
| GO ID | GO:0035050 |
|---|---|
| GO term | embryonic heart tube development |
| Ontology | biological_process |
| Synonym | None |
| Major function | Progression of the embryonic heart tube from formation to mature structure, including cardiac progenitor specification, tube folding, looping, and early chamber formation. |
| Related processes | Cardiac progenitor specification, heart field formation, cardiac looping, chamber specification, and cardiac neural crest contribution. |
| Key regulators | NKX2-5, TBX5, GATA4, MEF2C, HAND1, HAND2, ISL1, and signaling pathways such as BMP, FGF, and WNT. |
| Model organisms | Human pluripotent stem cell-derived embryo models, Drosophila, zebrafish, chick, and mouse. |
| Disease relevance | Congenital heart defects including septal defects, conotruncal anomalies, and left ventricular hypoplasia. |
What Is GO:0035050?
In our own words, GO:0035050 embryonic heart tube development refers to the coordinated series of cellular and morphogenetic events that transform the cardiac crescent or heart field into a linear, functional embryonic heart tube, and then guide its maturation into a structured organ. This includes progenitor specification, migration, folding, fusion, looping, and early chamber specification.
Why Is embryonic heart tube development Important in Cell Biology?
Embryonic heart tube development is important because it represents the earliest structural blueprint of the vertebrate heart, and errors in this process lead to congenital heart defects that affect approximately 1% of live births. The heart tube is the first functional organ in the embryo, and its proper formation is required for subsequent looping, chamber septation, and valve development. Studying GO:0035050 provides insight into fundamental mechanisms of organogenesis, cell fate specification, and tissue morphogenesis, and it informs regenerative strategies for cardiac repair.
• Congenital heart defects (CHDs) are the most common birth defects, and many arise from disrupted heart tube development.
• The heart tube is the first organ to function in the embryo, making its development critical for embryonic survival.
• Cardiac neural crest cells contribute to outflow tract septation, and their interaction with the heart tube is essential for normal development.
• Human pluripotent stem cell-derived embryo models that complete gastrulation to neurulation and organogenesis enable in vitro study of heart tube formation.
• Drosophila heart development provides conserved genetic insights into cardiac tube morphogenesis.
• Engineered heart tube platforms allow directed morphogenesis studies and drug testing.
• Understanding heart tube development informs regenerative medicine approaches for cardiac repair.
• Mutations in cardiac transcription factors such as NKX2-5, TBX5, and GATA4 are linked to CHDs.
• Signaling pathways including BMP, FGF, and WNT regulate heart field specification and tube formation.
• Research on GO:0035050 helps identify therapeutic targets for preventing or treating CHDs.
What Happens During embryonic heart tube development?
Cardiac progenitor specification and heart field formation
In simple terms: Early embryonic cells are instructed to become heart cells and organize into a heart-forming region.
During gastrulation, cardiac progenitors are specified within the anterior lateral plate mesoderm and form the cardiac crescent, also known as the first heart field. A second heart field population contributes to the outflow tract and right ventricle. Key transcription factors such as NKX2-5, GATA4, TBX5, and ISL1 establish cardiac progenitor identity and activate cardiac gene programs. Signaling pathways including BMP, FGF, and WNT coordinate the specification and migration of these progenitors to the midline.
Folding and fusion of the cardiac crescent into a linear heart tube
In simple terms: The flat heart-forming region folds and fuses to create a simple tube.
The cardiac crescent undergoes ventral folding and midline fusion to form a linear heart tube consisting of an inner endocardial layer and an outer myocardial layer separated by cardiac jelly. This morphogenetic event requires coordinated cell shape changes, extracellular matrix remodeling, and cell migration. The linear heart tube is initially straight and displays anterior-posterior polarity, with the future outflow tract at the anterior end and the inflow tract at the posterior end.
Cardiac looping and early chamber specification
In simple terms: The straight tube bends and twists to set up the future chambers.
The linear heart tube undergoes rightward looping, a process driven by asymmetric cell proliferation, cytoskeletal dynamics, and differential growth. Looping is essential for aligning the future chambers and outflow tract. Concurrently, chamber-specific gene expression programs are activated, including HAND1 and HAND2 for ventricular and atrial identity, and MEF2C for myocardial differentiation. Defects in looping lead to congenital heart defects such as dextrocardia and conotruncal anomalies.
Contribution of cardiac neural crest and second heart field
In simple terms: Additional cells from the neural crest and second heart field add to the growing heart tube.
Cardiac neural crest cells migrate into the outflow tract and contribute to septation of the aorta and pulmonary trunk. The second heart field, a population of progenitors located medially to the first heart field, adds cells to the arterial and venous poles of the heart tube, elongating the outflow tract and right ventricle. Disruption of neural crest or second heart field contributions results in outflow tract defects and septal anomalies.
Maturation into a multi-chambered heart
In simple terms: The tube remodels into a four-chambered heart with valves and septa.
Following looping, the heart tube undergoes septation and chamber maturation, forming the four-chambered heart with distinct atria, ventricles, and valves. This process involves endocardial cushion formation, myocardial trabeculation, and coronary vessel development. The transitional heart from early embryonic to fetal development is characterized by continuous remodeling and functional adaptation. Defects in maturation lead to a spectrum of congenital heart defects.
Key Genes Involved in GO:0035050 embryonic heart tube development
The following genes are well-established regulators of embryonic heart tube development, supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NKX2-5 | Cardiac progenitor specification and heart tube formation | Mutations cause congenital heart defects; key marker for cardiac differentiation |
| TBX5 | Heart tube patterning and chamber specification | Haploinsufficiency causes Holt-Oram syndrome; regulates cardiac gene expression |
| GATA4 | Cardiac gene activation and heart tube morphogenesis | Mutations linked to septal defects; essential for cardiac differentiation |
| MEF2C | Myocardial differentiation and chamber formation | Regulates sarcomeric gene expression; knockout causes cardiac defects |
| HAND1 | Ventricular and atrial chamber identity | Required for heart tube looping and chamber specification |
| HAND2 | Ventricular and outflow tract development | Regulates right ventricle and outflow tract formation |
| ISL1 | Second heart field progenitor maintenance | Marker of cardiac progenitors; required for outflow tract development |
| TBX1 | Pharyngeal arch and outflow tract development | Deleted in DiGeorge syndrome; causes conotruncal defects |
| PITX2 | Left-right asymmetry and cardiac looping | Regulates asymmetric heart morphogenesis |
| NODAL | Left-right axis specification | Controls cardiac looping direction |
| BMP4 | Heart field specification and cardiac jelly formation | Regulates progenitor differentiation and tube morphogenesis |
| FGF8 | Second heart field proliferation and outflow tract elongation | Required for cardiac progenitor expansion |
| WNT3A | Cardiac progenitor specification | Regulates mesoderm patterning |
| SOX9 | Cardiac neural crest migration | Required for outflow tract septation |
| PAX3 | Neural crest specification | Regulates cardiac neural crest contribution |
| SNAI1 | Epithelial-to-mesenchymal transition in endocardial cushions | Required for valve formation |
| VEGFA | Coronary vessel development | Regulates angiogenesis in the developing heart |
| ACTC1 | Sarcomeric actin in cardiomyocytes | Mutations cause cardiomyopathy and septal defects |
How Is embryonic heart tube development Regulated?
Embryonic heart tube development is regulated by a complex interplay of transcription factors, signaling pathways, and epigenetic modifiers. Key signaling pathways include BMP, FGF, WNT, and Notch, which control cardiac progenitor specification, proliferation, and differentiation. Transcription factors such as NKX2-5, TBX5, GATA4, and MEF2C form a core regulatory network that activates cardiac gene programs. Cardiac neural crest cells contribute to outflow tract septation through interactions with the second heart field. Additionally, mechanical forces and hemodynamic flow influence heart tube looping and chamber maturation. Epigenetic regulators, including chromatin remodelers, modulate cardiac gene expression during development.
embryonic heart tube development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NKX2-5 | Congenital heart defects, septal defects | Knockout and point mutation in human iPSCs and mouse |
| TBX5 | Holt-Oram syndrome, septal defects | Knock-in of patient mutations in iPSC-derived cardiomyocytes |
| TBX1 | DiGeorge syndrome, conotruncal defects | Knockout in mouse and human embryo models |
| GATA4 | Septal defects, cardiac hypertrophy | Overexpression and knockout in zebrafish and iPSCs |
| HAND1 | Left ventricular hypoplasia | Knockout in mouse and engineered heart tube platforms |
Congenital heart defects (CHDs)
Disruption of embryonic heart tube development is a primary cause of congenital heart defects, which affect approximately 1% of live births. Mutations in cardiac transcription factors such as NKX2-5, TBX5, and GATA4 are associated with septal defects, conotruncal anomalies, and conduction abnormalities. Cardiac neural crest defects lead to outflow tract malformations such as tetralogy of Fallot and persistent truncus arteriosus. Understanding the genetic and environmental factors influencing heart tube development is essential for diagnosis and prevention of CHDs.
DiGeorge syndrome and conotruncal anomalies
DiGeorge syndrome, caused by 22q11.2 deletion including TBX1, is characterized by conotruncal heart defects due to abnormal cardiac neural crest and second heart field contributions to the outflow tract. TBX1 haploinsufficiency disrupts pharyngeal arch artery development and outflow tract septation. This highlights the critical role of neural crest and second heart field interactions in heart tube development.
Left ventricular hypoplasia and chamber maturation defects
Defects in cardiac looping and chamber specification can lead to left ventricular hypoplasia, a severe congenital heart defect. Mutations in HAND1, HAND2, and MEF2C impair ventricular chamber formation and myocardial differentiation. These conditions often require surgical intervention and underscore the importance of understanding heart tube maturation.
From embryonic heart tube development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NKX2-5 disrupt heart tube formation? | CRISPR knockout in human iPSCs differentiated to cardiomyocytes |
| Does a TBX5 point mutation cause Holt-Oram syndrome phenotypes? | CRISPR knock-in of patient mutation in iPSCs |
| Can overexpression of HAND1 rescue chamber specification? | CRISPR overexpression in mouse embryos or iPSC-derived cardiac organoids |
| How does TBX1 haploinsufficiency affect outflow tract development? | Knockout in mouse and human embryo models |
| What is the role of cardiac neural crest in heart tube septation? | Lineage tracing and knockout in chick and mouse |
| Can engineered heart tubes model congenital heart defects? | Directed morphogenesis of embryonic heart tube on engineered platforms |
How to Study the embryonic heart tube development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identifying cardiac progenitor and heart tube transcriptomes |
| Single-cell RNA-seq | Cellular heterogeneity | Mapping heart field and heart tube cell populations |
| CRISPR knockout | Gene function loss | Testing candidate genes in heart tube development |
| CRISPR knock-in | Precise mutation introduction | Modeling patient-specific CHD mutations |
| Live imaging | Morphogenetic dynamics | Visualizing heart tube folding and looping |
| ATAC-seq | Chromatin accessibility | Identifying regulatory elements in cardiac development |
| Proteomics | Protein expression and interactions | Dissecting signaling networks in heart tube |
| Engineered heart tube platform | Directed morphogenesis | Modeling heart tube development in vitro |
Transcriptomic profiling (RNA-seq)
RNA sequencing of cardiac progenitors and heart tube cells at different developmental stages reveals dynamic gene expression changes and identifies novel regulators of heart tube development. Single-cell RNA-seq enables dissection of cellular heterogeneity within the heart field and heart tube.
Genome editing and lineage tracing
CRISPR-Cas9 knockout, knock-in, and overexpression in model organisms and human pluripotent stem cells allow functional testing of candidate genes in heart tube development. Lineage tracing using Cre-lox or CRISPR-based reporters maps the contribution of cardiac progenitors to the heart tube.
Imaging and morphogenesis assays
Live imaging of fluorescently labeled cardiac progenitors in zebrafish, chick, and mouse embryos visualizes heart tube folding, looping, and chamber formation. Engineered heart tube platforms provide controlled environments to study directed morphogenesis.
Proteomics and chromatin profiling
Proteomic analysis of heart tube tissues identifies protein complexes and signaling networks. ATAC-seq and ChIP-seq reveal chromatin accessibility and transcription factor binding at cardiac regulatory elements.
How CRISPR Can Be Used to Study GO:0035050 embryonic heart tube development
Knockout
CRISPR knockout of cardiac transcription factors such as NKX2-5, TBX5, or GATA4 in human iPSCs or model organisms ablates gene function and reveals essential roles in heart tube formation, looping, and chamber specification. Knockout models are used to validate candidate genes identified from patient genomics.
Point Mutation
CRISPR point mutation knock-in introduces patient-specific missense or nonsense mutations into endogenous loci, enabling precise modeling of congenital heart defects and functional assessment of variant pathogenicity. This approach is valuable for studying dominant-negative or hypomorphic alleles in heart tube development.
Knock-in
CRISPR knock-in of reporter genes (e.g., GFP, mCherry) or epitope tags into cardiac loci allows lineage tracing, live imaging, and biochemical analysis of heart tube development. Knock-in of conditional alleles (e.g., loxP) enables spatial and temporal control of gene expression.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression of cardiac genes such as HAND1 or MEF2C tests gain-of-function effects on heart tube morphogenesis and chamber specification. Overexpression models help identify sufficiency of candidate genes in driving cardiac differentiation.
How EDITGENE Supports embryonic heart tube development Research
Researchers studying embryonic heart tube development-related genes often need to determine whether a candidate gene is causally involved in cardiac progenitor specification, tube morphogenesis, or chamber formation. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for embryonic heart tube development research.
Frequently Asked Questions About embryonic heart tube development
What is embryonic heart tube development?
Embryonic heart tube development (GO:0035050) is the biological process whose specific outcome is the progression of the embryonic heart tube over time, from its formation to the mature structure, beginning with the heart rudiment from the heart field.
What genes are involved in embryonic heart tube development?
Key genes include NKX2-5, TBX5, GATA4, MEF2C, HAND1, HAND2, ISL1, TBX1, PITX2, NODAL, BMP4, FGF8, WNT3A, SOX9, PAX3, SNAI1, VEGFA, and ACTC1.
What are the stages of embryonic heart tube development?
The main stages are cardiac progenitor specification and heart field formation, folding and fusion of the cardiac crescent into a linear heart tube, cardiac looping and early chamber specification, contribution of cardiac neural crest and second heart field, and maturation into a multi-chambered heart.
How is embryonic heart tube development regulated?
It is regulated by transcription factors such as NKX2-5, TBX5, GATA4, and MEF2C, signaling pathways including BMP, FGF, WNT, and Notch, and contributions from cardiac neural crest and second heart field.
What diseases are associated with defects in embryonic heart tube development?
Defects cause congenital heart defects including septal defects, conotruncal anomalies, DiGeorge syndrome, and left ventricular hypoplasia.
What model systems are used to study embryonic heart tube development?
Model systems include human pluripotent stem cell-derived embryo models, Drosophila, zebrafish, chick, mouse, and engineered heart tube platforms.
How can CRISPR be used to study embryonic heart tube development?
CRISPR knockout, point mutation, knock-in, and overexpression enable functional testing of candidate genes in cardiac progenitor specification, tube morphogenesis, and chamber formation.
What is the role of cardiac neural crest in heart tube development?
Cardiac neural crest cells migrate into the outflow tract and contribute to septation of the aorta and pulmonary trunk, and their disruption causes outflow tract defects.
What is the second heart field?
The second heart field is a population of cardiac progenitors that adds cells to the arterial and venous poles of the heart tube, elongating the outflow tract and right ventricle.
Why is embryonic heart tube development important for regenerative medicine?
Understanding heart tube development informs strategies for generating cardiomyocytes from stem cells and for cardiac repair.
Conclusion
Embryonic heart tube development (GO:0035050) is a fundamental process in vertebrate organogenesis, integrating cardiac progenitor specification, morphogenesis, and chamber formation. Disruption of this process leads to congenital heart defects, making it a critical area of research. Advances in CRISPR genome editing, stem cell-derived embryo models, and imaging technologies continue to unravel the genetic and cellular mechanisms governing heart tube development. EDITGENE provides comprehensive CRISPR services to support functional studies of genes involved in this process.
References
- 1. Tan CMJ et al.. 2020. The Transitional Heart: From Early Embryonic and Fetal Development to Neonatal Life.. Fetal Diagn Ther 47(5):373-386 PMID: 31533099
- 2. Zubrzycki M et al.. 2024. Cardiac Development and Factors Influencing the Development of Congenital Heart Defects (CHDs): Part I.. Int J Mol Sci 25(13) PMID: 39000221
- 3. Mendjan S et al.. 2026. Coordination of cardiogenesis in vivo and in vitro.. Nat Rev Mol Cell Biol 27(1):19-34 PMID: 40993223
- 4. Amadei G et al.. 2022. Embryo model completes gastrulation to neurulation and organogenesis.. Nature 610(7930):143-153 PMID: 36007540
- 5. Thattaliyath BD et al.. 2024. Neural Crest.. Adv Exp Med Biol 1441:125-143 PMID: 38884708
- 6. Yamagishi H. 2021. Cardiac Neural Crest.. Cold Spring Harb Perspect Biol 13(1) PMID: 32071091
- 7. Gershlak JR et al.. 2026. Engineered Development: Directed Morphogenesis of an Embryonic Heart Tube.. Adv Mater 38(30):e22459 PMID: 42028886
- 8. Tao Y et al.. 2007. Heart development in Drosophila.. Semin Cell Dev Biol 18(1):3-15 PMID: 17208472
